Bile Duct Cancer Market Report 2026

Bile Duct Cancer Market Overview

• Bile Duct Cancer market size has reached to $2.59 billion in 2025 • Expected to grow to $3.89 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Rising Liver Disease Incidence To Fuel The Market Expansion • Market Trend: Innovative Targeted Therapies Transforming Treatment For Bile Duct Cancer • North America was the largest region in 2025.

What Is Covered Under Bile Duct Cancer Market?

Bile duct cancer refers to a rare type of cancer that forms in the bile ducts, which are the tubes that carry bile from the liver to the gallbladder and small intestine. It is typically diagnosed in its advanced stages and can lead to symptoms such as jaundice, weight loss, and abdominal pain. The main types of bile duct cancer are extrahepatic bile duct cancer (ECC) and intrahepatic bile duct cancer (ICC). Extrahepatic bile duct cancer (ECC) is a type of bile duct cancer that develops in the bile ducts outside the liver, typically in the area where the bile ducts exit the liver and connect to the small intestine. It has various treatment options, including surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. It is classified by stage into localized, regional, and distant forms, and diagnosis typically involves imaging tests, biopsy, and blood tests and is used by several end users, such as hospitals, clinics, ambulatory surgical centers, and cancer research institutes.

What Is The Bile Duct Cancer Market Growth Forecast?

The bile duct cancer market size is expected to see strong growth in the next few years. It will grow to $3.89 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing investment in precision oncology research, rising adoption of immunotherapy treatments, expansion of advanced diagnostic screening programs, growing use of ai-assisted cancer diagnostics, increasing focus on personalized cancer treatment pathways. Major trends in the forecast period include increasing adoption of targeted and immunotherapy treatments, rising use of advanced diagnostic imaging techniques, growing integration of multidisciplinary cancer care models, expansion of precision oncology approaches, enhanced focus on early detection and staging.

Global Bile Duct Cancer Market Segmentation

1) By Type: Extrahepatic Bile Duct Cancer (eCCA), Intrahepatic Bile Duct Cancer (iCCA) 2) By Treatment Type: Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy 3) By Stage of Disease: Localized, Regional, Distant 4) By Diagnosis Type: Imaging Tests, Biopsy, Blood Tests 5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes Subsegments: 1) By Extrahepatic Bile Duct Cancer (eCCA): Perihilar Cholangiocarcinoma (Klatskin Tumor), Distal Cholangiocarcinoma 2) By Intrahepatic Bile Duct Cancer (iCCA): Mass-Forming iCCA, Periductal Infiltrating iCCA, Intraductal Growth iCCA

What Is The Driver Of The Bile Duct Cancer Market?

The rising prevalence of liver diseases is expected to propel the growth of bile duct cancer going forward. Liver diseases refer to a range of conditions that affect the liver's ability to function properly, including hepatitis, cirrhosis, fatty liver disease, and liver cancer. The rising prevalence of liver diseases is primarily driven by factors such as increased alcohol consumption, unhealthy diets, obesity, viral infections like hepatitis, and a lack of regular physical activity. Bile duct cancer can help in understanding liver diseases by highlighting the critical role of bile ducts in liver function, as their obstruction or dysfunction often leads to liver-related complications such as jaundice and cholestasis. For instance, in July 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the global prevalence of chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD), reached approximately 30.2%, up from 26% in earlier estimates, indicating a growing population at risk for bile duct cancer. Therefore, rising prevalence of liver diseases is driving the growth of the bile duct cancer industry.

Key Players In The Global Bile Duct Cancer Market

Major companies operating in the bile duct cancer market are AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Merck & Co. Inc., Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Genentech Inc., Jazz Pharmaceuticals plc, Incyte Corporation, Exelixis Inc., Hutchison China MediTech Limited, Zymeworks Inc., Mirati Therapeutics Inc., RenovoRx Inc., Spectrum Pharmaceuticals Inc., Specialised Therapeutics Pty Ltd, Taiho Pharmaceutical Co. Ltd.

Global Bile Duct Cancer Market Trends and Insights

Major companies operating in the bile duct cancer market are focused on developing innovative solutions, such as targeted therapies, to improve treatment outcomes, reduce side effects, and offer new hope for patients with this rare and challenging cancer. Targeted therapies are treatments designed to focus on specific genes, proteins, or molecules that help cancer cells grow. These therapies work by blocking the processes that allow cancer to grow, aiming to stop tumor growth, reduce side effects, and improve treatment results. For instance, in August 2023, Taiho Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, announced the launch of FGFR Inhibitor LYTGOBI Tablets 4 mg. The tablet formulation of LYTGOBI offers a convenient oral administration option, enhancing patient compliance and ease of treatment. This launch provides a new therapeutic option for patients with advanced or metastatic bile duct cancer, particularly those who harbor FGFR2 fusion or rearrangement mutations, thereby addressing a critical unmet need in cancer care.

What Are Latest Mergers And Acquisitions In The Bile Duct Cancer Market?

In July 2023, Lucence, a US-based precision health company, partnered with Innovent Biologics Inc. With this partnership, Lucence aims to enhance its molecular diagnostic capabilities by incorporating Innovent Biologics' cutting-edge therapies, such as targeted treatments for bile duct cancer, into its testing services. Innovent Biologics Inc. is a China-based biotechnology company focused on the research, development, manufacturing, and commercialization of innovative biopharmaceuticals.

Regional Outlook

North America was the largest region in the bile duct cancer market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bile Duct Cancer Market?

The bile duct cancer market includes revenues earned by entities by services such as diagnostic services, treatment services, clinical trials, and research services, and related products such as pharmaceutical products, diagnostic products, and supportive care products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bile Duct Cancer Market Report 2026?

The bile duct cancer market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bile duct cancer industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.